News

The Neurologix procedure delivers a gene (glutamic acid decarboxylase, or GAD) to the subthalamic nucleus of the brain, where it makes an inhibitory neurotransmitter called GABA that helps

The FDA committee voted against approval of tedisamil, at this time, requesting Solvay Pharmaceuticals to provide additional information to the Agency. While not binding, the Committee’s recommendations will

The product portfolio consists of well-established pharmaceuticals such as Kavepenin, Heracillin, Kalcipos, and TrioBe. The acquisition is said to strengthen Meda’s home base in Sweden, and new product

Fast Track designation is reserved for new drugs that demonstrate the potential to address an unmet medical need and are intended for the treatment of a serious or

The data showed that a viral microRNA (miR-K12-11), which is encoded by KSHV, functions as a mimic of the host cell microRNA known as miR-155. Also, expression of

ISIS 333611 is a second-generation antisense drug in development for the treatment of amyotrophic lateral sclerosis (ALS) through the inhibition of Cu/Zn superoxide dismutase, a molecule that is

This multicenter, randomized, open-label Phase II study of IMC-1121B is enrolling patients with metastatic malignant melanoma who have not received prior chemotherapy for the disease. A total of

This fat transfer system is intended for use in the surgical specialties when the aspiration of soft tissue is desired, like plastic and reconstructive surgery, general surgery, neurosurgery,

Insmed has decided to initiate the Phase III enabling trial based on promising results from an ongoing open-label, dose-escalation trial of Iplex in myotonic muscular dystrophy (MMD). To